Bustamante, Regine Fher S.
HRN: 21-22-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/19/2023
10/26/2023
IVTT
43mg
Q8
Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes